Stockreport

Ipsen outlays $1bn for China-based Simcere's preclinical ADC [Yahoo! Finance]

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report
PDF The French drugmaker has signed a licensing deal with Simcere Zaiming for SIM0613, an ADC asset due to start clinical development in 2026. The agreement sees Ipsen secu [Read more]